Takano, M., & Sugiyama, T. (2017). UGT1A1 polymorphisms in cancer: Impact on irinotecan treatment. Pharmgenomics Pers Med.
Citação norma ChicagoTakano, Masashi, and Toru Sugiyama. "UGT1A1 Polymorphisms in Cancer: Impact On Irinotecan Treatment." Pharmgenomics Pers Med 2017.
ציטוט MLATakano, Masashi, and Toru Sugiyama. "UGT1A1 Polymorphisms in Cancer: Impact On Irinotecan Treatment." Pharmgenomics Pers Med 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.